NCT01847222View on ClinicalTrials.gov

An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

August 31, 2014

Conditions
Drug Safety
Interventions
BIOLOGICAL

SANGUINATE™

PEG-bHb-CO

DRUG

Normal Saline Solution

Placebo

Trial Locations (1)

Unknown

Rambam Health Care Facility, Haifa

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY